{"transactions":[{"id":4632840,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-10-03T00:46:51.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":10720,"price":5.83,"value":62497.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":440962,"source":{"system":"sec-edgar","filing":"0000885590-26-000115","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000115/form4.xml","form_type":"4"}},{"id":719766,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-07-02T20:11:53.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":12677,"price":4.93,"value":62497.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":430242,"source":{"system":"sec-edgar","filing":"0000885590-26-000093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000093/form4.xml","form_type":"4"}},{"id":737528,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-15T22:44:23.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":2253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units under the Acadian Asset Management Inc. 2026 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 12, 2026, the reporting person was granted 2,253 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset\nManagement Inc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 12, 2026, the reporting person was granted 2,253 restricted stock units vesting upon the earlier of June 12, 2027 and the date of the 2027 annual meeting of stockholders of Acadian Asset\nManagement Inc."}],"balance_after":2253,"derivative":{"underlying":"Common Stock","underlying_shares":2253},"source":{"system":"sec-edgar","filing":"0001628280-26-043346","document":"wk-form4_1781563460.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000162828026043346/wk-form4_1781563460.xml","form_type":"4"}},{"id":760341,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-05-28T21:07:04.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":15842,"price":15.78,"value":249986.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the annual grant of restricted share units (\"RSUs\") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders."}],"balance_after":89823,"source":{"system":"sec-edgar","filing":"0001860742-26-000079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000079/form4.xml","form_type":"4"}},{"id":764747,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-05-26T22:57:37.000Z","date":"2026-05-22","kind":"grant","planned":false,"acquired":true,"shares":45871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":417565,"source":{"system":"sec-edgar","filing":"0000885590-26-000080","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000080/form4.xml","form_type":"4"}},{"id":774491,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-18T20:09:50.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":false,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 14, 2025, the reporting person was granted 5,750 restricted stock units vesting upon the earlier of May 14, 2026 and the date of the 2026 annual meeting of stockholders of Acadian Asset Management Inc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 14, 2025, the reporting person was granted 5,750 restricted stock units vesting upon the earlier of May 14, 2026 and the date of the 2026 annual meeting of stockholders of Acadian Asset Management Inc."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001628280-26-035924","document":"wk-form4_1779134987.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000162828026035924/wk-form4_1779134987.xml","form_type":"4"}},{"id":774490,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:09:50.000Z","date":"2026-05-14","kind":"exercise","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29510,"source":{"system":"sec-edgar","filing":"0001628280-26-035924","document":"wk-form4_1779134987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000162828026035924/wk-form4_1779134987.xml","form_type":"4"}},{"id":795811,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-05-01T20:15:26.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":1375,"price":15.9,"value":21862.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":73981,"source":{"system":"sec-edgar","filing":"0001860742-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000065/form4.xml","form_type":"4"}},{"id":821506,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-04-02T22:20:34.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":11574,"price":5.4,"value":62499.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2026, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":371694,"source":{"system":"sec-edgar","filing":"0000885590-26-000045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000045/form4.xml","form_type":"4"}},{"id":888232,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-02-23T21:09:43.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":1239,"price":17.65,"value":21868.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":72606,"source":{"system":"sec-edgar","filing":"0001860742-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074226000016/form4.xml","form_type":"4"}},{"id":955827,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2026-01-02T21:08:45.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":8992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":360120,"source":{"system":"sec-edgar","filing":"0000885590-26-000003","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000003/form4.xml","form_type":"4"}},{"id":995966,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-11-18T21:23:35.000Z","date":"2025-11-14","kind":"grant","planned":false,"acquired":true,"shares":1402,"price":15.6,"value":21871.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":71367,"source":{"system":"sec-edgar","filing":"0001860742-25-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000186074225000027/form4.xml","form_type":"4"}},{"id":1028454,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-10-02T20:18:03.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":9689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":351128,"source":{"system":"sec-edgar","filing":"0000885590-25-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000088559025000039/form4.xml","form_type":"4"}},{"id":1067127,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2025-08-15T01:35:28.000Z","date":"2025-08-14","kind":"purchase","planned":false,"acquired":true,"shares":34721118,"price":9,"value":312490062.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":70755869,"source":{"system":"sec-edgar","filing":"0001013594-25-001065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359425001065/form4.xml","form_type":"4"}},{"id":1068251,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2025-08-13T22:51:24.000Z","date":"2025-08-13","kind":"purchase","planned":false,"acquired":true,"shares":86409,"price":7.06,"value":610047.54,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":36034751,"source":{"system":"sec-edgar","filing":"0001013594-25-001002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359425001002/form4.xml","form_type":"4"}},{"id":1068250,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2025-08-13T22:51:24.000Z","date":"2025-08-12","kind":"purchase","planned":false,"acquired":true,"shares":1156640,"price":6.88,"value":7957683.2,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":35948342,"source":{"system":"sec-edgar","filing":"0001013594-25-001002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359425001002/form4.xml","form_type":"4"}},{"id":1068249,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2025-08-13T22:51:24.000Z","date":"2025-08-11","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":6.35,"value":12700000.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":34791702,"source":{"system":"sec-edgar","filing":"0001013594-25-001002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359425001002/form4.xml","form_type":"4"}},{"id":1096632,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-07-02T20:50:14.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":9384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending June 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":341439,"source":{"system":"sec-edgar","filing":"0001127602-25-018689","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760225018689/form4.xml","form_type":"4"}},{"id":1108888,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2025-06-17T20:44:09.000Z","date":"2025-06-13","kind":"purchase","planned":false,"acquired":true,"shares":3564059,"price":5.94,"value":21170510.46,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":32791702,"source":{"system":"sec-edgar","filing":"0001013594-25-000764","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359425000764/form4.xml","form_type":"4"}},{"id":1114169,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2025-06-13T00:17:31.000Z","date":"2025-06-12","kind":"purchase","planned":false,"acquired":true,"shares":1005376,"price":5.47,"value":5499406.72,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":29227643,"source":{"system":"sec-edgar","filing":"0001013594-25-000742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359425000742/form4.xml","form_type":"4"}},{"id":1114168,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2025-06-13T00:17:31.000Z","date":"2025-06-11","kind":"purchase","planned":false,"acquired":true,"shares":1029098,"price":5.24,"value":5392473.52,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":28222267,"source":{"system":"sec-edgar","filing":"0001013594-25-000742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359425000742/form4.xml","form_type":"4"}},{"id":1114167,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2025-06-13T00:17:31.000Z","date":"2025-06-10","kind":"purchase","planned":false,"acquired":true,"shares":754134,"price":5.05,"value":3808376.7,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson Capital Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":27193169,"source":{"system":"sec-edgar","filing":"0001013594-25-000742","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359425000742/form4.xml","form_type":"4"}},{"id":1132121,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-05-28T20:08:28.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":20338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the annual grant of restricted share units (\"RSUs\") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders."}],"balance_after":69965,"source":{"system":"sec-edgar","filing":"0001127602-25-015804","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760225015804/form4.xml","form_type":"4"}},{"id":1141161,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-05-20T20:28:25.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":54347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":332055,"source":{"system":"sec-edgar","filing":"0001127602-25-015022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760225015022/form4.xml","form_type":"4"}},{"id":1147062,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-15T21:53:52.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc."},{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of restricted stock units issued under the Acadian Asset Management Inc. Non-Employee Directors' Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On May 14, 2025, the reporting person was granted 5,750 restricted stock units vesting upon the earlier of May 14, 2026 and the date of the 2026 annual meeting of stockholders of Acadian Asset Management Inc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On May 14, 2025, the reporting person was granted 5,750 restricted stock units vesting upon the earlier of May 14, 2026 and the date of the 2026 annual meeting of stockholders of Acadian Asset Management Inc."}],"balance_after":5750,"derivative":{"underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001748824-25-000041","document":"wk-form4_1747346025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882425000041/wk-form4_1747346025.xml","form_type":"4"}},{"id":1147061,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-15T21:53:52.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":7764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of Acadian Asset Management Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 7, 2024, the reporting person was granted 7,764 restricted stock units vesting upon the earlier of June 7, 2025 and the date of the 2025 annual meeting of stockholders of Acadian Asset Management Inc., which was held on May 13, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 7, 2024, the reporting person was granted 7,764 restricted stock units vesting upon the earlier of June 7, 2025 and the date of the 2025 annual meeting of stockholders of Acadian Asset Management Inc., which was held on May 13, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7764},"source":{"system":"sec-edgar","filing":"0001748824-25-000041","document":"wk-form4_1747346025.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882425000041/wk-form4_1747346025.xml","form_type":"4"}},{"id":1147060,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T21:53:52.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":7764,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23760,"source":{"system":"sec-edgar","filing":"0001748824-25-000041","document":"wk-form4_1747346025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882425000041/wk-form4_1747346025.xml","form_type":"4"}},{"id":1159427,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-05-05T20:00:47.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":1887,"price":11.59,"value":21870.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":49627,"source":{"system":"sec-edgar","filing":"0001127602-25-013331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760225013331/form4.xml","form_type":"4"}},{"id":1187154,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-04-01T20:34:05.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":9659,"price":6.47,"value":62493.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending March 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":277708,"source":{"system":"sec-edgar","filing":"0001127602-25-010795","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760225010795/form4.xml","form_type":"4"}},{"id":1319163,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-01-02T12:51:18.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":7754,"price":8.06,"value":62497.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":268049,"source":{"system":"sec-edgar","filing":"0001127602-25-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760225000002/form4.xml","form_type":"4"}},{"id":1396863,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-10-01T23:12:59.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":1134,"price":19.29,"value":21874.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":48874,"source":{"system":"sec-edgar","filing":"0001127602-24-024769","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224024769/form4.xml","form_type":"4"}},{"id":1397326,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-10-01T20:15:16.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":7659,"price":8.16,"value":62497.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":260295,"source":{"system":"sec-edgar","filing":"0001127602-24-024684","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760224024684/form4.xml","form_type":"4"}},{"id":1439691,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-08-06T22:04:04.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":14696,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the annual grant of restricted stock units (\"RSUs\") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders."}],"balance_after":47740,"source":{"system":"sec-edgar","filing":"0001127602-24-021758","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224021758/form4.xml","form_type":"4"}},{"id":1463327,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-07-02T21:36:26.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1506,"price":14.52,"value":21867.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":33044,"source":{"system":"sec-edgar","filing":"0001127602-24-019938","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224019938/form4.xml","form_type":"4"}},{"id":1466563,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-07-01T20:45:39.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":8967,"price":6.97,"value":62499.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units issued?in?lieu?of?cash?compensation?in?connection with the Reporting Person's service on the Issuer's Board?of?Directors for the quarter ending June 30, 2024, each representing a contingent right to receive one common share, no par value, of the Issuer."}],"balance_after":252636,"source":{"system":"sec-edgar","filing":"0001127602-24-019572","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760224019572/form4.xml","form_type":"4"}},{"id":1484564,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-10T21:09:12.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":7764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2024, the reporting person was granted 7,764 restricted stock units vesting upon the earlier of June 7, 2025 and the date of the 2025 annual meeting of stockholders of BrightSphere Investment Group Inc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2024, the reporting person was granted 7,764 restricted stock units vesting upon the earlier of June 7, 2025 and the date of the 2025 annual meeting of stockholders of BrightSphere Investment Group Inc."}],"balance_after":7764,"derivative":{"underlying":"Common Stock","underlying_shares":7764},"source":{"system":"sec-edgar","filing":"0001748824-24-000030","document":"wk-form4_1718053745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882424000030/wk-form4_1718053745.xml","form_type":"4"}},{"id":1484563,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-10T21:09:12.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":7662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 8, 2023, the reporting person was granted 7,662 restricted stock units vesting upon the earlier of June 8, 2024 and the date of the 2024 annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 6, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 8, 2023, the reporting person was granted 7,662 restricted stock units vesting upon the earlier of June 8, 2024 and the date of the 2024 annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 6, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7662},"source":{"system":"sec-edgar","filing":"0001748824-24-000030","document":"wk-form4_1718053745.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882424000030/wk-form4_1718053745.xml","form_type":"4"}},{"id":1484562,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T21:09:12.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":7662,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15996,"source":{"system":"sec-edgar","filing":"0001748824-24-000030","document":"wk-form4_1718053745.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882424000030/wk-form4_1718053745.xml","form_type":"4"}},{"id":1509681,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-05-20T21:59:26.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":35360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":243669,"source":{"system":"sec-edgar","filing":"0001127602-24-016035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760224016035/form4.xml","form_type":"4"}},{"id":1553872,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-04-02T20:07:24.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":1264,"price":17.3,"value":21867.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":31538,"source":{"system":"sec-edgar","filing":"0001127602-24-011816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224011816/form4.xml","form_type":"4"}},{"id":1557036,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-04-01T20:33:36.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":5890,"price":10.61,"value":62492.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":208309,"source":{"system":"sec-edgar","filing":"0001127602-24-011596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760224011596/form4.xml","form_type":"4"}},{"id":1693110,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-01-03T21:42:32.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":1282,"price":17.06,"value":21870.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":30274,"source":{"system":"sec-edgar","filing":"0001127602-24-000487","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760224000487/form4.xml","form_type":"4"}},{"id":1697185,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-01-02T21:16:46.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":7793,"price":8.02,"value":62499.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":202419,"source":{"system":"sec-edgar","filing":"0001127602-24-000125","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760224000125/form4.xml","form_type":"4"}},{"id":1767831,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-10-03T21:16:59.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":1290,"price":16.95,"value":21865.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":28992,"source":{"system":"sec-edgar","filing":"0001127602-23-025314","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223025314/form4.xml","form_type":"4"}},{"id":1770920,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-10-02T20:27:19.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":7603,"price":8.22,"value":62496.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":194626,"source":{"system":"sec-edgar","filing":"0001127602-23-025004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760223025004/form4.xml","form_type":"4"}},{"id":1836715,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-07-05T20:11:06.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":1089,"price":20.07,"value":21856.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":27702,"source":{"system":"sec-edgar","filing":"0001127602-23-020012","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223020012/form4.xml","form_type":"4"}},{"id":1838112,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-07-05T20:06:39.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":7812,"price":8,"value":62496.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":187023,"source":{"system":"sec-edgar","filing":"0001127602-23-019997","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760223019997/form4.xml","form_type":"4"}},{"id":1860162,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-09T22:18:06.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":7662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 8, 2023, the reporting person was granted 7,662 restricted stock units vesting upon the earlier of June 8, 2024 and the date of the 2024 annual meeting of stockholders of BrightSphere Investment Group Inc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 8, 2023, the reporting person was granted 7,662 restricted stock units vesting upon the earlier of June 8, 2024 and the date of the 2024 annual meeting of stockholders of BrightSphere Investment Group Inc."}],"balance_after":7662,"derivative":{"underlying":"Common Stock","underlying_shares":7662},"source":{"system":"sec-edgar","filing":"0001748824-23-000043","document":"wk-form4_1686349077.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882423000043/wk-form4_1686349077.xml","form_type":"4"}},{"id":1860161,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-09T22:18:06.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":false,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 1, 2023, the reporting person was granted 8,334 restricted stock units vesting upon the earlier of June 8, 2023 and the date of the annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 7, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 1, 2023, the reporting person was granted 8,334 restricted stock units vesting upon the earlier of June 8, 2023 and the date of the annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 7, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001748824-23-000043","document":"wk-form4_1686349077.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882423000043/wk-form4_1686349077.xml","form_type":"4"}},{"id":1860160,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T22:18:06.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":true,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On May 1, 2023, the reporting person was granted 8,334 restricted stock units vesting upon the earlier of June 8, 2023 and the date of the annual meeting of stockholders of BrightSphere Investment Group Inc., which was held on June 7, 2023."}],"balance_after":8334,"source":{"system":"sec-edgar","filing":"0001748824-23-000043","document":"wk-form4_1686349077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882423000043/wk-form4_1686349077.xml","form_type":"4"}},{"id":1885839,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-05-19T20:27:33.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":29205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":179211,"source":{"system":"sec-edgar","filing":"0001127602-23-016304","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760223016304/form4.xml","form_type":"4"}},{"id":1903030,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-05-05T20:29:22.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":12857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the annual grant of restricted stock units (\"RSUs\") to non-employee directors under the Amended and Restated Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders."}],"balance_after":26613,"source":{"system":"sec-edgar","filing":"0001127602-23-014705","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223014705/form4.xml","form_type":"4"}},{"id":1907997,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-02T20:03:25.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a right to receive one share of common stock of BrightSphere Investment Group Inc."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units issued under the BrightSphere Investment Group Inc. Non-Employee Directors' Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest upon the earlier of June 8, 2023 and the date of the 2023 annual meeting of stockholders of BrightSphere Investment Group Inc."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest upon the earlier of June 8, 2023 and the date of the 2023 annual meeting of stockholders of BrightSphere Investment Group Inc."}],"balance_after":8334,"derivative":{"underlying":"Common Stock","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001748824-23-000025","document":"wf-form4_168305778945045.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000174882423000025/wf-form4_168305778945045.xml","form_type":"4"}},{"id":1930375,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-04-04T22:04:32.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":7716,"price":8.1,"value":62499.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":150006,"source":{"system":"sec-edgar","filing":"0001127602-23-012411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760223012411/form4.xml","form_type":"4"}},{"id":1928848,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-04-04T20:22:53.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":1256,"price":17.41,"value":21866.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation."}],"balance_after":13756,"source":{"system":"sec-edgar","filing":"0001127602-23-012204","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000112760223012204/form4.xml","form_type":"4"}},{"id":2073496,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-01-03T22:04:57.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":9952,"price":6.28,"value":62498.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":142290,"source":{"system":"sec-edgar","filing":"0001127602-23-000168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760223000168/form4.xml","form_type":"4"}},{"id":2148061,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-10-03T21:15:46.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":9071,"price":6.89,"value":62499.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Amended Form 4 is being filed to correct the number of RSUs acquired on September 30, 2022 as reported on the Form 4 filed on October 3, 2022."}],"balance_after":132338,"source":{"system":"sec-edgar","filing":"0001127602-22-023292","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222023292/form4a.xml","form_type":"4/A","original_submission_date":"2022-10-03"}},{"id":2148058,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-10-03T20:46:36.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":2732,"price":6.89,"value":18823.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":125999,"source":{"system":"sec-edgar","filing":"0001127602-22-023267","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222023267/form4.xml","form_type":"4"}},{"id":2215762,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-07-05T23:28:03.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":2251,"price":8.36,"value":18818.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":123267,"source":{"system":"sec-edgar","filing":"0001127602-22-018840","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222018840/form4.xml","form_type":"4"}},{"id":2220541,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-06-28T20:51:49.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":34387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":121016,"source":{"system":"sec-edgar","filing":"0001127602-22-018209","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222018209/form4.xml","form_type":"4"}},{"id":2273676,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, No Par Value","published_at":"2022-05-12T23:37:35.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the \"Plan\"). Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation (the \"Company\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs are scheduled to vest on the date of the first regular annual meeting of the Company's shareholders in 2023, subject to the reporting person's continued service through such date."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0000899243-22-017854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000089924322017854/doc4.xml","form_type":"4"}},{"id":2309824,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-04-04T21:53:54.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":1340,"price":22.85,"value":30619.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":86629,"source":{"system":"sec-edgar","filing":"0001127602-22-011284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222011284/form4.xml","form_type":"4"}},{"id":2455125,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-01-03T21:12:08.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":1109,"price":27.61,"value":30619.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":85289,"source":{"system":"sec-edgar","filing":"0001127602-22-000095","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222000095/form4.xml","form_type":"4"}},{"id":2553145,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2021-10-04T20:46:22.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":1099,"price":27.85,"value":30607.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":84180,"source":{"system":"sec-edgar","filing":"0001127602-21-026454","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221026454/form4.xml","form_type":"4"}},{"id":2646167,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2021-07-02T20:13:39.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":1044,"price":29.32,"value":30610.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":83081,"source":{"system":"sec-edgar","filing":"0001127602-21-021229","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221021229/form4.xml","form_type":"4"}},{"id":2733562,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2021-05-03T20:09:51.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":7645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":82037,"source":{"system":"sec-edgar","filing":"0001127602-21-014911","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221014911/form4.xml","form_type":"4"}},{"id":2762611,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2021-04-02T21:14:55.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":952,"price":31.74,"value":30216.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":74392,"source":{"system":"sec-edgar","filing":"0001127602-21-012752","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221012752/form4.xml","form_type":"4"}},{"id":2926570,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2021-01-04T23:56:29.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":1442,"price":20.8,"value":29993.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":73440,"source":{"system":"sec-edgar","filing":"0001127602-21-000248","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221000248/form4.xml","form_type":"4"}},{"id":3017340,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2020-10-02T21:02:36.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":1930,"price":15.54,"value":29992.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":71998,"source":{"system":"sec-edgar","filing":"0001127602-20-026308","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220026308/form4.xml","form_type":"4"}},{"id":3093680,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2020-07-02T20:30:41.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":1545,"price":18.29,"value":28258.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":70068,"source":{"system":"sec-edgar","filing":"0001127602-20-020914","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220020914/form4.xml","form_type":"4"}},{"id":3098306,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock, par value $0.001 per share","published_at":"2020-06-26T21:46:13.000Z","date":"2020-06-24","kind":"sale","acquired":false,"shares":647263,"price":9.79,"value":6336704.77,"ownership":{"direct":false,"nature":"By Paulson & Co. Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson & Co.\"), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds (the \"Funds\"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson & Co.\"), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds (the \"Funds\"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represent rebalancing transactions between the Funds."}],"balance_after":20000552,"source":{"system":"sec-edgar","filing":"0001013594-20-000562","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000101359420000562/form4.xml","form_type":"4"}},{"id":3098305,"issuer":{"id":4180,"kind":"organization","name":"Acadian Asset Management Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"ten_percent_owner":true}}],"security":"Common Stock, par value $0.001 per share","published_at":"2020-06-26T21:46:13.000Z","date":"2020-06-24","kind":"purchase","acquired":true,"shares":647263,"price":9.79,"value":6336704.77,"ownership":{"direct":false,"nature":"By Paulson & Co. Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson & Co.\"), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds (the \"Funds\"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson & Co.\"), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds (the \"Funds\"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Represent rebalancing transactions between the Funds."}],"balance_after":20647815,"source":{"system":"sec-edgar","filing":"0001013594-20-000562","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000101359420000562/form4.xml","form_type":"4"}},{"id":3149704,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":585100,"price":15.92,"value":9314792.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":25839035,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149703,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":624900,"price":15.87,"value":9917163.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":25253935,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149702,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":70000,"price":15.65,"value":1095500.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":24629035,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149701,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-14","kind":"purchase","acquired":true,"shares":348920,"price":15.85,"value":5530382.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":24559035,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149700,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-13","kind":"purchase","acquired":true,"shares":645844,"price":16.7,"value":10785594.8,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":24210115,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149699,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-13","kind":"purchase","acquired":true,"shares":80300,"price":16.58,"value":1331374.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":23564271,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149698,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-13","kind":"purchase","acquired":true,"shares":603900,"price":16.32,"value":9855648.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":23483971,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149697,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-12","kind":"purchase","acquired":true,"shares":799900,"price":17.24,"value":13790276.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":22880071,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149696,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-12","kind":"purchase","acquired":true,"shares":678400,"price":17.47,"value":11851648.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":22080171,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149695,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-12","kind":"purchase","acquired":true,"shares":374836,"price":17.33,"value":6495907.88,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":21401771,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149694,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-12","kind":"purchase","acquired":true,"shares":162900,"price":17.5,"value":2850750.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":21026935,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3149693,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, no par value","published_at":"2020-05-14T22:25:55.000Z","date":"2020-05-12","kind":"purchase","acquired":true,"shares":25000,"price":17.3,"value":432500.0,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer.  Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\").  John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."}],"balance_after":20864035,"source":{"system":"sec-edgar","filing":"0001013594-20-000496","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000101359420000496/form4.xml","form_type":"4"}},{"id":3165812,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2020-05-01T20:23:46.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":11037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $200,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":68523,"source":{"system":"sec-edgar","filing":"0001127602-20-015034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220015034/form4.xml","form_type":"4"}},{"id":3187719,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2020-04-02T20:26:27.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":1774,"price":15.5,"value":27497.0,"ownership":{"direct":true},"balance_after":57486,"source":{"system":"sec-edgar","filing":"0001127602-20-012705","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220012705/form4.xml","form_type":"4"}},{"id":3328058,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2020-01-02T21:34:37.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":919,"price":29.92,"value":27496.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":55712,"source":{"system":"sec-edgar","filing":"0001127602-20-000176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220000176/form4.xml","form_type":"4"}},{"id":3401857,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2019-10-02T21:39:36.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":1258,"price":21.85,"value":27487.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":54793,"source":{"system":"sec-edgar","filing":"0001127602-19-029780","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219029780/form4.xml","form_type":"4"}},{"id":3472846,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2019-07-02T20:12:52.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":1090,"price":25.22,"value":27489.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":53535,"source":{"system":"sec-edgar","filing":"0001127602-19-023537","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219023537/form4.xml","form_type":"4"}},{"id":3540846,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2019-05-03T20:16:52.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":10633,"price":23.51,"value":249981.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Bausch Health Companies Inc. (\"Bausch Health\") on the third business day following their election at the Annual Meeting of Shareholders of Bausch Health (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Bausch Health's next Annual Meeting, and are settled in common shares, no par value, of Bausch Health."}],"balance_after":52445,"source":{"system":"sec-edgar","filing":"0001127602-19-017266","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219017266/form4.xml","form_type":"4"}},{"id":3566578,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2019-04-03T20:55:00.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":1113,"price":24.7,"value":27491.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":41812,"source":{"system":"sec-edgar","filing":"0001127602-19-014668","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219014668/form4.xml","form_type":"4"}},{"id":3628581,"issuer":{"id":156504,"kind":"organization","name":"BrightSphere Investment Group plc","symbol":"BSIG"},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2019-02-27T22:02:35.000Z","date":"2019-02-25","kind":"purchase","acquired":true,"shares":14790038,"price":13.95,"value":206321030.1,"ownership":{"direct":false,"nature":"By Paulson & Co. Inc."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson & Co.\"), serves on the board of directors of the Issuer. Paulson & Co. is an investment advisor registered under the Investment Advisors Act of 1940. Paulson & Co. is the investment manager of investment funds. John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by Paulson & Co. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Each of John Paulson and Paulson & Co. may be deemed to indirectly beneficially own the securities directly owned by Paulson & Co.. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4."}],"balance_after":20000552,"source":{"system":"sec-edgar","filing":"0001567619-19-005499","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394923/000156761919005499/doc1.xml","form_type":"4"}},{"id":3710910,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2019-01-03T21:27:41.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":1488,"price":18.47,"value":27483.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":40699,"source":{"system":"sec-edgar","filing":"0001127602-19-000700","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219000700/form4.xml","form_type":"4"}},{"id":3803132,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-10-02T20:35:50.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":1071,"price":25.67,"value":27492.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Share Units (\"RSUs\") representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc."}],"balance_after":39211,"source":{"system":"sec-edgar","filing":"0001127602-18-029064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218029064/form4.xml","form_type":"4"}},{"id":3876980,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-07-03T20:41:55.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":1183,"price":23.24,"value":27492.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Share Units (\"RSUs\") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc."}],"balance_after":38140,"source":{"system":"sec-edgar","filing":"0001127602-18-022655","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218022655/form4.xml","form_type":"4"}},{"id":3943317,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-05-08T20:36:42.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":13881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. (\"Valeant\") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Amended Form 4 is being filed to correct the number of RSUs acquired on May 3, 2018 as reported on the Form 4 filed on May 4, 2018."}],"balance_after":36957,"source":{"system":"sec-edgar","filing":"0001127602-18-016652","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218016652/form4a.xml","form_type":"4/A","original_submission_date":"2018-05-04"}},{"id":3946117,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-05-04T21:56:37.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":14285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of Valeant Pharmaceuticals International, Inc. (\"Valeant\") on the third business day following their election at the Annual Meeting of Shareholders of Valeant (the \"Annual Meeting\").  The RSUs have a grant date value equal to $250,000, vest immediately prior to Valeant's next Annual Meeting, and are settled in common shares, no par value, of Valeant."}],"balance_after":37361,"source":{"system":"sec-edgar","filing":"0001127602-18-016409","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218016409/form4.xml","form_type":"4"}},{"id":3974759,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true}}],"security":"Common Stock, No Par Value","published_at":"2018-04-03T20:54:34.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":1727,"price":15.92,"value":27493.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Share Units (\"RSUs\") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc."}],"balance_after":23076,"source":{"system":"sec-edgar","filing":"0001127602-18-013758","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218013758/form4.xml","form_type":"4"}},{"id":4006636,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2018-03-08T22:04:35.000Z","date":"2018-03-06","kind":"purchase","acquired":true,"shares":7066629,"price":15.4,"value":108826086.6,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represent rebalancing transactions between the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represent rebalancing transactions between the Funds."}],"balance_after":20839035,"source":{"system":"sec-edgar","filing":"0001140361-18-012637","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000114036118012637/doc1.xml","form_type":"4"}},{"id":4006635,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33372,"kind":"person","name":"Paulson John","position":1,"cik":"0001394923","reported_name":"Paulson John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, no par value","published_at":"2018-03-08T22:04:35.000Z","date":"2018-03-06","kind":"sale","acquired":false,"shares":7066629,"price":15.4,"value":108826086.6,"ownership":{"direct":false,"nature":"By Managed Funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Represent rebalancing transactions between the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"John Paulson, the controlling person of Paulson & Co. Inc. (\"Paulson\"), serves on the board of directors of the Issuer. Paulson is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the \"Funds\"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the \"Act\"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represent rebalancing transactions between the Funds."}],"balance_after":13772406,"source":{"system":"sec-edgar","filing":"0001140361-18-012637","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000114036118012637/doc1.xml","form_type":"4"}}],"next_cursor":"2018-03-08T22:04:35.000000Z,4006635"}